DEMOGRAPHIC PATTERNS
In contrast to syphilis, for example, chlamydial infections are most commonly reported among adolescents; in 1995, the rate for 15-19 year olds was five times higher than the overall rate for all ages (see figure). While this difference may be inflated because of screening programs that target this age group, there is no getting around the fact that sexual activity in general and "unsafe" sex in particular are very common among teens and young adults-also putting them at risk for other sexually transmitted diseases and pregnancy.
In general, reported Chlamydia rates are much lower for males, and this difference is most pronounced among 15-19 year olds (see figure, verso) . Historically, screening programs have been targeted primarily at young women, who are much more likely to develop symptomatic infections. Although little research has been done to explain why, anecdotal accounts suggest that males are less likely to volunteer for examination.
† Confirming that there is no justice in the world of STDs, women are also much more likely to suffer serious sequelae of infection. Lower genital tract infection can progress to endometrial and tubal infection and, in turn, to complications such as infertility, ectopic pregnancy, and chronic pelvic pain.
DIAGNOSTIC CHALLENGES
Early detection and treatment of cervical infections clearly represents an important avenue for the prevention of PID. 1 However, the diagnosis can be difficult because many infected women do not have characteristic signs or symptoms. Early detection relies mainly on screening high risk women using sensitive and specific laboratory tests. Although culture of endocervical swab specimens has been considered the diagnostic gold standard for confirmation of cervical chlamydial infection in women, 3 other screening methods may now be more sensitive.
In men, C. trachomatis can cause nonspecific urethritis, and is often asymptomatic. Traditional testing methods (e.g., culture, EIA, DFA, and nucleic acid probes) all require the discomfort of a urethral swab. A variety of methods for detecting Chlamydia in urine have been tested, but urine cultures have been generally a waste of time. Antigen detection of methods using centrifuged first-void urine have proven moderately successful, but this approach has not been as sensitive as culturing urethral swabs, 5 especially in asymptomatic men.
NEW LCR TEST LICENSED
In December 1995, the FDA licensed a new diagnostic test for Chlamydia infections. According to advertising hype, the Ligase Chain Reaction (LCR) test is able to detect the presence of as few as 1-5 organisms through the miracle of DNA replication. In contrast, traditional tests require as many as 100,000 organisms in a clinical specimen for detection.
2 LCR assays can be used with comparable effectiveness on both swab or urine samples. Given the relative ease of collecting the latter, urine may be worth a closer look.
Culture studies indicate that 50-60% of women infected with C. trachomatis have infections in both the cervix and the urethra; 30% are infected in the cervix alone; and 5-30% are infected in the urethra alone. Urine samples may contain organisms from the urethra or the cervix, whereas an endocervical swab should not contain organisms from an infected urethra. Thus, given a urine assay that is sufficiently sensitive and specific, urine testing should identify a higher proportion of infected women than testing of endocervical swabs alone. Available evidence suggests that the LCR assay is highly effective for the detection of C. trachomatis in urine from women-with or without signs or symptoms of genitourinary tract infection. LCR urine assays pick up some 30% more * Incidentally, hepatitis A rates in Oregon have plummeted in 1996. As of October 11, "only" 687 cases had been reported, compared with 2368 by this time last year. Our soap shipment finally arrived, apparently. infections than swab cultures. One drawback of only using LCR testing of urine for screening programs is that other disorders that might be diagnosed during a pelvic examination may be missed. The options for evaluating symptom-free women warrant further study. 3 For men, LCR testing of first-void urine is a most excellent alternative to urethral swabbing for detecting C. trachomatis urethral infections. 5 The sensitivity of this test (depending on the study) ranges from 93 to 98% and the specificity approaches 100%. In contrast, urine culture has a sensitivity on the order of 7-9%. Culture or antigen detection from a urethral swab or antigen detection on concentrated urine have a sensitivity of 45-95%, depending on the assay, specimen transport, and other factors.
CAVEATS AND CONCLUSIONS
The exceptional performance of this new test suggests that it could become the preferred test for the diagnosis of genitourinary tract infections with C. trachomatis. Oregon is one of the few states that have begun using LCR assays in selected health department settings. All is not sweetness and light, however. Urine specimens to be tested by LCR must be kept
RECOMMENDED TREATMENT REGIMENS
The recommended* regimens for uncomplicated urethral, endocervical, or rectal chlamydial infections among adults are:
• doxycycline (100 mg p.o. bid x 7 days), or • azithromycin (1 g Were LCR tests to be widely used, we could see an increase in the number of reported cases over the next few yearsespecially among young males-as a higher proportion of cases are diagnosed. Ultimately, of course, reduction of disease rates will depend not only upon the successful detection and treatment of carriers but our ability to reduce the behaviors that lead to disease transmission. 
